Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-03-21

Clinical Trial Update: Benefits of Oxytocin in Obstructive Sleep Apnea (OSA) Patients Using Continuous Positive Airway Pressure (CPAP) Machine [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating the benefits of oxytocin in obstructive sleep apnea patients using CPAP.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxytocin (Oxytocin)

Snippet

Sponsor: Vivek Jain | Conditions: Sleep Apnea, Sleep Apnea, Obstructive | Phase 1 | Status: RECRUITING